Tectonic Therapeutic Inc. Company Profile
NASDAQ: TECXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Tectonic Therapeutic at a glance
Tectonic Therapeutic Inc. (NASDAQ: TECX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Watertown, MA. Tectonic Therapeutic is led by Dr. Alise S. Reicin M.D., Ph.D. and employs about 60 people. The company's shares have traded publicly since 2018.
At a market capitalization of $405.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001681087, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Tectonic Therapeutic do?
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Tectonic Therapeutic Inc.
- Ticker
- NASDAQ: TECX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Alise S. Reicin M.D., Ph.D.
- Employees
- 60
- Headquarters
- 490 Arsenal Way, Watertown, MA, United States
- Phone
- 339 666 3320
- Website
- tectonictx.com
- IPO year
- 2018
- Market cap
- $405.26M
- SEC CIK
- 0001681087
- Latest annual report
- 10-K · Feb 26, 2026
Companies similar to Tectonic Therapeutic
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TVGNTevogen Inc. | 5.90 | -6.35% | $405.20M | vs TECX |
| CADLCandel Therapeutics Inc. | 5.04 | -1.75% | $395.37M | vs TECX |
| PROKProKidney Corp. Class A | 1.04 | -1.89% | $415.21M | vs TECX |
| IRLAIRulya Therapeutics Inc. | 39.88 | -0.15% | $432.36M | vs TECX |
| FENCFennec Pharmaceuticals Inc. | 13.09 | -2.68% | $462.14M | vs TECX |
| ALECAlector Inc. | 2.34 | +1.52% | $347.63M | vs TECX |
| RGNXREGENXBIO Inc. | 7.16 | -0.28% | $473.44M | vs TECX |
| SANASana Biotechnology Inc. | 1.59 | -8.62% | $476.42M | vs TECX |